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We read with interest the editorial comment by S.
Daneshmand [1] regarding our recent article. The fact
that lymph node metastases are found unexpectedly in
the pathological specimens of up to 27% of patients
with preoperatively staged cN0 muscle-invasive blad-
der cancer makes an extended pelvic lymph node
dissection (ePLND) mandatory [2]. A significant
number of these lymph node-positive patients have
contralateral lymph node metastases. We therefore
fully agree with the editorial comment that this argues
for a bilateral ePLND, as demonstrated and clearly
stated in our article [3]. Indeed, even in lymph node-
positive bladder cancer patients in whom the tumor was
strictly localized on the lateral bladder wall of a single
bladder hemisphere, 27% of patients had contralateral
lymph node metastases [3]. No positive lymph node,
however, was found in the internal iliac (called by some
the presacral) region contralateral to the tumor.
Although we greatly appreciate the opinion of S.
Daneshmand and understand his concern, we respect-
fully disagree with his viewpoint that another study
has already found positive nodes in the contralateral
internal iliac region in unilateral bladder cancer strictly
localized on the lateral bladder wall [4]. Indeed, in
that study the authors examined tumors located in a
single bladder hemisphere including tumors involv-
ing the bladder neck, trigone, and/or posterior bladder
wall, regions well known to drain everywhere within
the pelvis [5, 6]. This points out a major drawback
of every retrospective analysis, namely that the exact
tumor site is difficult to evaluate retrospectively. It
must be borne in mind that tumors located unilater-
ally (located within a single bladder hemisphere) are
not equal to tumors located strictly laterally within a
single bladder hemisphere as in the cohort of bladder
cancer patients in our recent article [2]. We perform
a cystoscopy (including exam under anesthesia and
urethral biopsies) as a standard procedure in every
bladder cancer patient scheduled for radical cystec-
tomy in order to facilitate an individualized approach
(e.g. nerve sparing, seminal vesical sparing). During
this examination we also determine the localization of
the tumor. This is why we can select the patients who
might be candidates for a limited lymphadenectomy on
the contralateral site, namely those with tumors located
strictly unilaterally on the lateral bladder wall.
As confirmed by several studies and in agreement
with the editorial comment, any kind of PLND is bet-
ter than none, and an extended PLND is better than a
limited PLND [7, 8]. In future, however, further indi-
vidualization of PLND templates depending on the
localization of the bladder tumor might be an option in
some patients. It must always be borne in mind, how-
ever, that these patients have to be carefully selected
and that this approach is certainly not suitable for
all patients or all institutions. In any case, the best
functional and oncological results can be achieved if
ePLND, radical cystectomy, and urinary diversion are
performed in a high-volume hospital (at least 40–50
cases annually) by high-volume surgeons working with
an experienced team [9]. Only then is there a guaran-
tee of adequate patient selection leading to the best
available therapeutic practices and results.
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